Daniel Levin

USPTO Granted Patents = 35 (Patent Applications = 21)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 16)

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 86(Granted Patents)

Location History:

La Canada, CA (2022)
La Canada, CA (US) (2013 - 2024)

Company Filing History:

21 out of 25

Neonc Technologies, Inc.

University of Southern California

patents

6. 1 out of 1

Neone Technologies, Inc.

patent

7. 1 out of 23

Firmenich Incorporated

patents

8. 1 out of 10

Vistagen Therapeutics, Inc.

patents

Years Active: 2013-2025

Loading Chart...

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12383621 - Pharmaceutical compositions comprising POH derivatives (2025-08-12),

2. 11970436 - Pharmaceutical compositions comprising monoterpenes (2024-04-30),

3. 11559508 - Pharmaceutical compositions comprising POH derivatives and methods of use (2023-01-24),

4. 11479554 - Pharmaceutical compositions comprising perillyl alcohol derivatives (2022-10-25),

5. 11427530 - Synthesis of 4-chlorokynurenines and intermediates (2022-08-30),

6. 11077104 - Pharmaceutical compositions comprising POH derivatives (2021-08-03),

7. 11013804 - Pharmaceutical compositions comprising POH derivatives (2021-05-25),

8. 10899691 - Pharmaceutical compositions comprising monoterpenes (2021-01-26),

9. 10696680 - Pharmaceutical compositions comprising perillyl alcohol derivatives (2020-06-30),

10. 10570105 - Processes and intermediates for making sweet taste enhancers (2020-02-25),

11. 10457618 - Pharmaceutical compositions comprising monoterpenes (2019-10-29),

12. 10399920 - Crystalline form of cannabidiol (2019-09-03),

13. 10308621 - Processes and intermediates for making sweet taste enhancers (2019-06-04),

14. 10092562 - Pharmaceutical compositions comprising POH derivatives (2018-10-09),

15. 10087154 - Processes and intermediates for making sweet taste enhancers (2018-10-02),

Title: Exploring the Innovations of Inventor Daniel Levin from La Canada, CA

Introduction:

Daniel Levin, a prolific inventor hailing from La Canada, CA, has made significant contributions to the field of pharmaceutical compositions through his innovative patents. With an impressive portfolio of 34 patents, Levin's focus on developing purifying processes for monoterpenes and sesquiterpenes showcases his dedication to advancing medical treatments.

Latest Patents:

Among Levin's latest patents is a groundbreaking process for purifying monoterpenes and sesquiterpenes to a purity exceeding 98.5% (w/w). These purified compounds form the basis of pharmaceutical compositions that hold promise in treating diseases such as cancer. By co-administering these compounds with radiation or other therapeutic agents, Levin's inventions offer new avenues for combating complex medical conditions.

Career Highlights:

Levin's career boasts stints at renowned companies such as Neonc Technologies, Inc. and Senomyx, Inc., where he honed his skills as an inventive force in the pharmaceutical industry. His expertise in developing novel treatments has garnered recognition within the scientific community, positioning him as a leader in implementing cutting-edge solutions for healthcare challenges.

Collaborations:

Throughout his career, Levin has collaborated with esteemed professionals like Thomas C. Chen and Satish Puppali. Together, they have leveraged their collective knowledge to propel forward-thinking research initiatives and bring inventive ideas to fruition. Levin's collaborative spirit has been instrumental in fostering a culture of innovation within the companies he has been a part of.

Conclusion:

Inventor Daniel Levin's unwavering commitment to pushing the boundaries of pharmaceutical innovation exemplifies his impact on the field. Through his pioneering patents and collaborative efforts, Levin continues to drive progress in developing advanced therapies for critical illnesses. His legacy as a visionary inventor is marked by a relentless pursuit of excellence and a steadfast dedication to improving patient outcomes in the realm of healthcare.

This text is generated by artificial intelligence and may not be accurate.